Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 540,957 | 386,800 | 259,099 | 72,041 | 1,558 |
| Cost of Goods | 64,437 | 45,059 | 28,366 | 6,696 | N/A |
| Gross Profit | 476,520 | 341,741 | 230,733 | 65,345 | 1,558 |
| Operating Expenses | 326,319 | 254,741 | 196,490 | 165,799 | 138,643 |
| Operating Income | 150,638 | 87,059 | 34,609 | -99,758 | -137,085 |
| Interest Expense | 704 | 606 | 2,407 | 2,489 | 2,837 |
| Other Income | -923 | -3,139 | 2,528 | 9,212 | 8,035 |
| Pre-tax Income | 149,011 | 83,314 | 34,730 | -93,035 | -131,887 |
| Income Tax | 51,981 | -211,852 | 1,581 | -745 | -373 |
| Net Income Continuous | 97,030 | 295,166 | 33,149 | -92,290 | -131,514 |
| Net Income | $97,030 | $295,166 | $33,149 | $-92,290 | $-131,514 |
| EPS Basic Total Ops | 0.54 | 1.73 | 0.22 | -0.64 | -1.04 |
| EPS Basic Continuous Ops | 0.54 | 1.73 | 0.21 | -0.64 | -1.04 |
| EPS Diluted Total Ops | 0.52 | 1.63 | 0.20 | -0.64 | -1.04 |
| EPS Diluted Continuous Ops | 0.52 | 1.63 | 0.18 | -0.64 | -1.04 |
| EBITDA(a) | $166,430 | $99,532 | $42,217 | $-94,831 | $-133,379 |